We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » PTAB Invalidates Fresenius’ Patent on General Anesthetic Propofol
PTAB Invalidates Fresenius’ Patent on General Anesthetic Propofol
The PTO’s Patent Trial and Appeal Board invalidated several claims relating to the manufacture of the widely used anesthetic Diprivan (propofol), in a patent held by Fresenius Kabi.